Bromer Matthew Q, Weinberg David S
Gastroenterology Division, Temple University Medical School, Philadelphia, PA, USA.
Semin Oncol. 2005 Feb;32(1):3-10. doi: 10.1053/j.seminoncol.2004.09.031.
When used appropriately, screening for colorectal cancer (CRC) can reduce disease-related morbidity and mortality. Current methods include fecal occult blood testing (FOBT), flexible sigmoidoscopy [FS], barium enema, and colonoscopy; all are cost-effective techniques. Unfortunately, offering an array of options has not increased screening utilization, which continues to lag behind that of other common cancers. Newer techniques, particularly virtual colonoscopy (VC) and stool DNA testing, may offer attractive alternatives for healthcare provider recommendation and patient use.
当合理使用时，结直肠癌（CRC）筛查可降低疾病相关的发病率和死亡率。目前的方法包括粪便潜血试验（FOBT）、乙状结肠镜检查[FS]、钡灌肠和结肠镜检查；所有这些都是具有成本效益的技术。不幸的是，提供一系列筛查选项并未提高筛查的利用率，结直肠癌筛查的利用率仍落后于其他常见癌症。更新的技术，特别是虚拟结肠镜检查（VC）和粪便DNA检测，可能为医疗服务提供者的推荐和患者的使用提供有吸引力的替代方案。
